Pharma and PBM argue over rising drug costs amid public scrutiny
Nadzeya Haroshka Leading pharmaceutical lobbying group PhRMA and drug brokers known as pharmacy benefit managers (PBMs) have resumed their long-running ...
Nadzeya Haroshka Leading pharmaceutical lobbying group PhRMA and drug brokers known as pharmacy benefit managers (PBMs) have resumed their long-running ...
According to Web3 executives, a sharp collapse in the price of non-fungible tokens (NFTs) should not be seen as a ...
Ethereum core developers plan to implement a 64-fold increase in the minimum amount of Ether (ETH) required to become a ...